Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (CTRI/2026/10/119258) titled 'A Study to Compare How Quickly and for How Long Ranitidine and Pantoprazole Reduce Stomach Acid in Patients with Gastroesophageal Reflux Disease-GERD' on Oct. 9.
Study Type: PMS
Study Design:
Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:An Open list of random numbers Blinding and masking:Open Label
Primary Sponsor: Torrent Pharma
Condition:
Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis
Intervention:
Intervention1: Ranitidine 150 mg tablet: Ranitidine 1...